Mexico Mulls 30% Tobacco Tax Hike from 2026; Industry Warns of Illicit Market Growth and Revenue Losses

Sep.22.2025
Mexico Mulls 30% Tobacco Tax Hike from 2026; Industry Warns of Illicit Market Growth and Revenue Losses
Mexico’s National Tobacco Industry Council (Conainta) has raised concerns over a federal proposal to increase the Special Tax on Production and Services (IEPS) on cigarettes and nicotine products by more than 30% starting in 2026, and to levy up to a 200% tax on alternative nicotine products. Conainta and the Mexican Confederation of Industrial Chambers (Concamin) estimate illicit consumption could climb to 50%, with annual fiscal losses of MXN 13–15 billion.

Key Points

 

• Tax proposal: At least MXN 20 per pack increase; from 2030 the specific quota would rise from MXN 0.6445 to MXN 1.1584 per cigarette; up to 200% tax on alternative nicotine products.

 

• Industry stance: Conainta says higher taxes have not proven to reduce consumption or increase revenues; IEPS receipts on manufactured tobacco fell 7% year over year in 2024 (MXN 50.4bn → MXN 46.9bn).

 

• Illicit-market risk: Concamin estimates illicit consumption could reach 50%, implying MXN 13–15bn in annual fiscal losses.

 

• Research data: The National Institute of Public Health reports a 240% surge in illicit cigarettes from 2017–2023 (8.5% → 20.4% of the market); El Colegio de México links the trade to organized crime, including drug trafficking, human trafficking, and money laundering.

 

• Alternatives debate: A proposed 200% tax on products such as nicotine pouches drew criticism; industry argues these combustion-free products may emit “up to 99% fewer toxic substances.”

 

• Call to action: Industry urges Congress to pursue a “balanced” fiscal reform that advances public health, combats illicit trade, and maintains sustainable revenues.

 


 

2Firsts, September 22 2025 — From primerapersona's Report, Conainta has voiced concerns about a government bill submitted to Congress to raise IEPS on cigarettes and nicotine products by more than 30% from 2026. The proposal includes a minimum increase of MXN 20 per pack and, from 2030, an increase in the specific quota from MXN 0.6445 to MXN 1.1584 per cigarette. It also contemplates an excise of up to 200% on alternative nicotine products.

 

Conainta—whose members include Philip Morris Mexico, British American Tobacco, and Japan Tobacco International—argues that similar measures have not demonstrated effectiveness in reducing consumption or boosting revenue. Despite prior rate hikes, IEPS receipts on manufactured tobacco reportedly declined by 7% year on year, from MXN 50.4 billion in 2023 to MXN 46.9 billion in 2024.

 

Illicit trade is a central concern. Concamin estimates that, if enacted, the reform could push illicit consumption to 50%, generating annual fiscal losses of MXN 13–15 billion. Supporting this outlook, the National Institute of Public Health reports that the illicit cigarette market expanded by 240% between 2017 and 2023, rising from 8.5% to 20.4% share. In parallel, an analysis by El Colegio de México says illicit tobacco has become a funding source for organized crime, with links to drug trafficking, human trafficking, and money laundering.

 

Debate also surrounds taxation of lower-risk alternatives. Industry stakeholders argue that products such as nicotine pouches are combustion-free and may produce “up to 99% fewer toxic substances,” warning that a 200% excise could undercut harm-reduction strategies. Sweden is cited as a reference case, where encouraging alternatives has been associated with a smoking rate near 5%.

 

Conainta has called on Congress to open dialogue and craft a balanced reform that jointly advances public health, constrains the illicit market, and protects sustainable fiscal revenues. It advocates tax design that accounts for market enforceability and administrative capacity, to avoid widening price gaps that could inadvertently bolster gray and black markets.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma Passes Tobacco and Nicotine Ingredient Disclosure Bill, Targeting 2027 End to Trade-Secret Protection for Certain Harmful Ingredient Data
Russia's State Duma passed a government-sponsored amendment on November 11, 2026, by 414 votes to none, seeking to prevent businesses from classifying information on the presence and number of types of certain harmful ingredients in tobacco and nicotine-containing products as trade secrets. The measure covers ingredients capable of increasing nicotine dependence or exhibiting toxic, carcinogenic, mutagenic or reproductive toxicity, including substances that acquire such properties during heating or smoldering. Bill No. 1286415-8 would amend Article 5 of Federal Law No. 98-FZ on Commercial Secrets and is scheduled to take effect on January 1, 2027. The bill has cleared all three readings in the State Duma but has not completed the remaining legislative procedures.
Regulations
Nov.12 by 2Firsts Perspectives
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City Opens Lottery for 55 Vape Retail License Slots Across 23 Community Districts, Including 28 in Brooklyn
New York City's Department of Consumer and Worker Protection (DCWP) opened applications on November 2, 2026, for a lottery covering tobacco and electronic cigarette retail dealer licenses, with a deadline of 5 p.m. New York local time on November 30. According to the city's October 1 notice, 55 electronic cigarette retail license slots are available across 23 community districts, including 28 in Brooklyn, alongside 322 tobacco retail license slots across 41 districts. Businesses must enter the lottery and, if invited, complete licensing requirements within 65 days. New York City continues to restrict e-cigarette retail sales to tobacco-flavored or unflavored products, while city retail licenses do not replace FDA product marketing authorization.
Market
Nov.04
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
UK ONS Data: Vaping Rate Among Women Aged 25–34 Reaches 18.3%, Compared With 14.4% for Men
The vaping rate among women aged 25 to 34 in Great Britain reached 18.3% in 2025, up from 13.7% in 2024 and 8.3% in 2020, according to data from the Office for National Statistics (ONS). The figure was the highest for this group since records began in 2014 and exceeded the 14.4% recorded among men of the same age. Adults aged 25 to 34 also overtook those aged 16 to 24 as the age group with the highest vaping prevalence. Overall, about 5.4 million adults in Great Britain used e-cigarettes in 2025, broadly unchanged from the previous year.
DATA
Oct.13
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14